Stryker Corp
XMUN:SYK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Stryker Corp
XMUN:SYK
|
US |
|
M
|
Moatech Co Ltd
KOSDAQ:033200
|
KR |
|
A
|
Amplia Therapeutics Ltd
OTC:INNMF
|
AU |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
B
|
BCWorldPharm Co Ltd
KOSDAQ:200780
|
KR |
|
D
|
Diodes Inc
F:DDQ
|
US |
Wall St Price Targets
SYK Price Targets Summary
Stryker Corp
According to Wall Street analysts, the average 1-year price target for SYK is 343.28 EUR with a low forecast of 278.36 EUR and a high forecast of 427.18 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SYK's stock price target?
Price Target
343.28
EUR
According to Wall Street analysts, the average 1-year price target for SYK is 343.28 EUR with a low forecast of 278.36 EUR and a high forecast of 427.18 EUR.
What is the Revenue forecast for Stryker Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 8%.
What is the Gross Profit forecast for Stryker Corp?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Stryker Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 7 years is 13%.
What is the Pre-Tax Income forecast for Stryker Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Stryker Corp?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 7 years is 19%.
